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Negative Cooperativity of Uric Acid Binding to the
Transcriptional Regulator HucR from Deinococcus
radiodurans





Members of the MarR family of winged helix transcriptional regulators
have been shown to regulate multidrug and oxidative stress response,
pathogenesis, and catabolism of aromatic compounds. Many respond to
anionic lipophilic compounds in their capacity to bind DNA, and the co-
crystal structure of MarR bound to salicylate revealed two ligand-binding
pockets, SAL-A and SAL-B. The MarR homolog, HucR, from Deinococcus
radiodurans has been shown to repress expression of a predicted uricase,
and DNA-binding by HucR is antagonized by uric acid, the substrate of
uricase. We provide a biochemical investigation of DNA-binding and uric
acid-binding by HucR. Equilibrium analytical ultracentrifugation indicates
that HucR exists as a dimer. Intrinsic fluorescence spectra suggest that the
association of the HucR dimer with its cognate DNA involves confor-
mational flexibility in the globular interior and/or dimerization domain of
the protein, and near-UV circular dichroism spectra indicate a concomitant
change in the helical twist of the DNA duplex. DNA-binding affinity,
measured by electrophoretic mobility-shift assays, for HucR mutants
bearing single amino acid substitutions suggests the importance of the
b-hairpin “wing” in DNA binding. Analysis of intrinsic fluorescence
spectra demonstrates that uric acid induces conformational changes in
HucR and binds with an apparent KdZ11.6(G3.7) mM and a Hill coefficient
of 0.7G0.1, indicating negative cooperativity. Fluorescence and DNA-
binding properties of the HucR variants indicate that SAL-A is a low-
affinity, uric acid-binding site and that negative cooperativity exists
between homologous, high-affinity sites. The conservation of residues
comprising site SAL-A suggests that it is a low-affinity, ligand-binding site
in MarR homologs. Mechanistic considerations suggest that HucR is
regulated by uric acid to maintain optimal cellular levels of this scavenger
of free radicals in response to oxidative stress and DNA damage.
q 2005 Elsevier Ltd. All rights reserved.
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Introduction
The identification of the MarR (multiple anti-
biotic resistance regulator) family of transcriptional
regulators was initiated by genetic experiments that
identified strains ofEscherichia coliK-12with enhanced
resistance to structurally diverse antibiotics, oxidative
stress agents, and organic solvents.1–5 The locus
responsible for the resistance phenotype was ident-
ified as the marRAB operon.6,7 Transcriptional repres-
sion was shown to be conferred by the product of the
first gene of this operon, MarR, which binds with
high affinity (Kdw1 nM) as a homodimer to two
sites in the marRAB promoter/operator region.4,8
MarR-mediated repression was shown to be
relieved, both in vitro and in vivo, by structurally
diverse phenolic compounds, including some of the
antimicrobial agents to which the operon confers
resistance.4,9–11 Structural determination identified
MarR as a winged helix DNA-binding protein.12
0022-2836/$ - see front matter q 2005 Elsevier Ltd. All rights reserved.
Abbreviations used: HucR, hypothetical uricase reg-
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Numerous prokaryotic MarR homologs with
physiological regulatory roles in antibiotic and
oxidative stress response (MarR, MexR, EmrR, PecS,
and HucR), the production of virulence factors (PecS
and ExpG), and the catabolism of aromatic com-
pounds (HpaR, HpcR, CinR, BadR, CbaR, HucR, and
HcaR) have since been identified.9,13–19 The DNA-
binding capacities of a number of these MarR family
members have been shown to be altered by anionic
lipophilic compounds, often by the suggested target
of the regulated genes.
The structure of the MarR dimer bound to the
effector salicylate has been resolved at 2.3 Å,
revealing two ligand-binding sites, designated as
SAL-A and SAL-B, on either side of the proposed
DNA recognition helix.12 The proximity of the
ligand-binding sites in MarR to residues shown to
be critical for MarR binding activity20 suggested a
potential mechanism of regulation. In addition, the
crystal structure of an MarR family member, MexR
from Pseudomonas aeruginosa, has been resolved at
2.1 Å.18 Several conformational states of the MexR
dimer were observed in the asymmetric unit,
suggesting that the mechanism of ligand-induced
effects on the DNA-binding activity of this protein
involves alterations to the relative orientations of
the DNA binding domains from each half of the
dimer. However, without combined structural data
for each protein in its DNA-bound, ligand-bound,
and apo conformations, the DNA-binding and
ligand-response mechanisms of these MarR homo-
logs remain unknown.
We previously reported the biochemical charac-
terization of HucR, a novel MarR homolog from
Deinococcus radiodurans.17 HucR binds as a homo-
dimer with very high affinity (KdZ0.3 nM) to a
single 21 bp site containing E. coli s70-like promoter
elements driving its own expression and that of an
adjacent, predicted uricase (dr1160) (shown to be a
functional enzyme in vitro; our unpublished
results). The affinity of HucR for its cognate binding
sequence is antagonized by certain anionic lipophi-
lic compounds, most notably uric acid. Analyses
in vivo indicate that uric acid upregulates transcrip-
tion of hucR and dr1160 in D. radiodurans and
suggest that uricase activity in D. radiodurans total
protein extracts is increased in cells grown in the
presence of uric acid.
In this study, we provide the first biochemical
investigation into the mechanisms of DNA inter-
action and ligand response for a member of the
MarR family. Spectroscopic evidence reveals that
the mechanism by which HucR binds its sequence-
specific, DNA-binding site involves conformational
flexibility in the protein and in the DNA helix. We
show that HucR possesses at least two uric acid-
binding sites, with dissimilar ligand-binding affi-
nities. Moreover, our data suggest that the highly
conserved ligand-binding site corresponding to
SAL-A in MarR is a weak ligand-binding site in
HucR, indicating that antagonistic effect of uric acid
on HucR-DNA interaction is not mediated primar-
ily by the SAL-A site.
Results
Complex formation is accompanied by
conformational changes in both HucR and hucO
Previous footprinting analyses of the binding
interaction between HucR and its sequence-specific
double-stranded DNA-binding site suggested that
the process involved deformation of the DNA.17 To
assess the role of conformational changes in the
DNA double helix in the HucR binding mechanism,
we used circular dichroism (CD) spectroscopy to
analyze HucR-mediated changes in the secondary
structure of a 31 bp DNA fragment (hucO-31)
containing the 21 bp HucR binding site. Protein
contributions to the CD signal in the near UV are
minimal; above 240 nm, ellipticity is dominated by
contributions from the purine and pyrimidine bases
of the DNA duplex. The CD spectrum of hucO-31 is
characteristic of B-form DNA (Figure 1(a)). Under
stoichiometric binding conditions with a molar
ratio of HucR dimer:DNA of 1:1 yielding 100%
saturation of hucO-31, HucR induced a significant
Figure 1. Binding-induced conformational changes in
DNA and protein. (a) Near-UV CD spectra of 2 mM hucO
in the absence of protein (black, filled circles) or in
complex with 4 mMHucR (red, open triangles). Data were
corrected for protein and solvent contributions to the
signal. HucR–hucO-31 complex formation was verified by
an electrophoretic mobility-shift assay (data not shown).
(b) DNA-induced changes in the intrinsic fluorescence
spectrum of HucR. The intrinsic fluorescence spectrum of
1.52 mM HucR was measured in the absence or in the
presence of increasing concentrations of hucO-31: 0:1
molar ratio of hucO-31 to HucR (black, filled circle); 0.25:1
(red, filled square); 0.5:1 (green, diamond); 0.75:1 (blue,
triangle); 1:1 (orange, inverted triangle).
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increase in the magnitude of the positive CD band
at 275 nm. Changes in the ellipticity band at 275 nm
have been correlated with changes in the DNA
winding angle.21–24 The HucR-mediated effect on
the hucO-31 CD band at 275 nm is consistent with
an increase in the number of base-pairs per turn of
the DNA, or a decrease in the helical twist of the
DNA duplex.
Secondary structure prediction algorithms
suggest that the HucR monomer is composed of
seven a-helices and two b-strands,25,26 with helices
4 and 5 comprising the two a-helices of the helix-
turn-helix motif. HucR contains two tryptophan
residues, located at positions 20 and 72 in the
primary amino acid sequence, and two tyrosine
residues, at positions 62 and 79. Secondary struc-
ture prediction places W20 in helix 1, Y62 in helix 2,
and W72 and Y79 in helix 3. Structural modeling of
HucR, and structural analysis of the homologs
MexR and MarR, places helix 3 in the globular
interior of the monomer and helices 1 and 2 at the
dimer interface (Figure 2). None of these residues is
expected to be in the wing or DNA recognition helix
and hence changes in the intrinsic fluorescence
spectrum of HucR would indicate altered environ-
ments of the fluorophores in the dimerization
domains and hydrophobic cores of the homodimer.
Using an excitation wavelength of 280 nm, the
measured emission signal is dominated by the
tryptophan residues, which have a much higher
quantum yield relative to tyrosine. The intrinsic
fluorescence of HucR was measured as a function of
hucO-31 concentration to monitor protein confor-
mational changes upon complex formation
(Figure 1(b)). The intrinsic fluorescence spectrum
of HucR is characterized by an emission maximum
at 338 nm and a “shoulder” at 328 nm. Titration of
HucR with hucO resulted in a significant quenching
of the entire fluorescence spectrum, with no change
in the wavelength of maximal fluorescence or in the
relative intensity of the shoulder. This quenching
effect was saturated at an hucO to HucR monomer
molar ratio of 0.5:1, consistent with previous work
demonstrating that HucR binds its cognate DNA
site as a homodimer. This observation, an electro-
phoretic mobility-shift assay (EMSA) showing
complete saturation of DNA at a 1:1 stoichiometry
of HucR dimer to DNA, and footprinting analyses
revealing a pseudopalindromic binding sequence,17
indicate that the protein is largely active.
The equilibrium sedimentation profile of HucR
was attained to determine the oligomeric state of
HucR in the absence of DNA (Figure 3). Data were
best fit to a model describing a single, non-
associating protein species, yielding a molecular
mass average of 43,016G4374 for HucR. As the
molecular mass of an HucR monomer calculated
from its primary amino acid sequence is 19.7 kDa,
the equilibrium sedimentation data suggest that
HucR exists predominantly as a homodimer in the
absence of DNA. Although we cannot rigorously
rule out other association models, the reported
Figure 2. Model of HucR monomer. The known
structure of the closely related MarR family member,
MexR, was used as a template to model HucR via SWISS-
MODEL. The predicted DNA recognition helix is colored
green. The b-strands and loop comprising with “wing”
motif are colored blue and yellow, respectively. Side-
chains of S104 and R118 are shown in red, ball and stick
representation. The backbone position of P89, part of the
MarR SAL-A pocket, is colored magenta. W20 and W72
are indicated in orange. The N terminus is labeled N.
Residues 178–181 of HucR are not shown.
Figure 3. Equilibrium sedimentation profile of HucR.
The absorbance of 40 mMHucR (monomer equivalents) is
shown as a function of the radial cell position (lower
panel). Data were fit to a model describing a single, non-
associating, species. Residuals to the fit were distributed
randomly (upper panel).
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association model is consistent with crystallo-
graphic and biochemical data for other MarR
homologs.12,18,19,27 Also, this supports the accuracy
of the Kd value of 0.3 nM reported for the HucR
dimer–hucO association, as the binding mechanism
is likely uncomplicated by monomer–dimer
equilibrium.
Uric acid–HucR interactions
Uric acid was shown to be an efficient negative
effector of the capacity of HucR to bind its cognate
DNA, with a concentration of 0.26 mM being
required to reduce HucR–DNA complex formation
to 50%, compared to 5.2 mM for salicylic acid, and
46 mM for acetylsalicylic acid.17 To monitor binding
of HucR to its ligands, we measured the intrinsic
fluorescence of HucR as a function of ligand
concentration. Absorption limitations at the exci-
tation wavelength of 280 nm determined the
maximum concentration of ligand for which
fluorescence intensities could be fully corrected
for inner filter effects. At concentrations up to
50 mM, uric acid induced a strong quenching effect
on the emission spectra of HucR. The quenching of
the fluorescence emission maximum at 338 nm as a
function of the concentration of uric acid was fit to
the Hill equation, yielding an apparent dissociation
constant for HucR–uric acid interaction of 11.6(G
3.7) mM (Figure 4(a)). The fit provided a Hill
coefficient (nH) of 0.7G0.1, suggesting negative
cooperativity. Analysis of the data using equations
for non-equivalent, non-interacting sites resulted in
fits with large error, suggesting that measurements
of fluorescence quenching at concentrations of uric
acid below 50 mM predominantly monitors binding
at higher-affinity binding site(s), and that the
observed negative cooperativity is either between
equivalent sites in a protein homodimer, or between
the higher-affinity site and one, or more, lower-
affinity ligand-binding sites within the same mono-
mer. Confirmation of negative cooperativity is
providedbytransformationof thedata (Figure4(b)).28
A Scatchard plot of uric acid-induced quenching of
HucRfluorescence at 338 nmreveals a cleardeviation
from linearity, and the direction of the curvature is
indicative of negative cooperativity. The double-
reciprocal plot is hyperbolic, also indicating negative
cooperativity (Figure 4(b)).28,29 Separate titrations of
HucR with salicylic acid and acetylsalicylic acid up
to final concentrations of 100 mM and 120 mM,
respectively, resulted in essentially no effect on the
intrinsic fluorescence of HucR (Figure 4(a)),
consistent with previous data showing little effect
on DNA–HucR complex formation at these
compound concentrations.17
To monitor the effects of higher concentrations of
ligand on HucR fluorescence, the emission spectra
were corrected for inner filter effects of ligand
absorbance at emission wavelengths, and absor-
bance at the excitation wavelength was compen-
sated for by normalizing the emission spectrum to
the maximal fluorescence intensity. In this way,
alterations to the HucR emission spectrum could be
observed, in addition to the fluorescence quenching
observed at low concentrations of uric acid.
Titration of HucR with uric acid resulted in a
gradual red-shift in the wavelength of maximal
fluorescence, from 338 nm for unbound HucR to
341 nm at 200 mM uric acid (Figure 5). This red shift
saturated at 200 mM uric acid, as the fluorescence
maximum remained at 341 nm at concentrations of
uric acid up to 1 mM. The fluorescence shoulder,
characteristic of the HucR spectrum, is sensitive to
the concentration of uric acid. The shoulder
intensity, relative to the fluorescence maximum,
Figure 4. Binding isotherms for HucR–ligand inter-
actions, at low concentrations of ligand. Quenching of
HucR fluorescence at 338 nm is plotted against concen-
tration of ligand: uric acid (filled circles, continuous line);
salicylic acid (filled squares, broken line); acetylsalicylic
acid (filled triangles, dotted line). Data were collected up
to 100 mM salicylic acid and 120 mM acetylsalicylic acid,
demonstrating no fluorescence quenching.
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underwent a gradual quenching with increasing
concentration of uric acid. These effects on the
HucR emission spectrum were not induced by the
low-affinity ligands, salicylic acid and acetylsa-
licylic acid (Supplementary Data, Figure S1). In
comparison to the red shift observed with uric acid,
separate titrations up to a concentration of 1 mM for
each compound did not shift the wavelength of
maximum fluorescence from 338 nm. In addition,
neither salicylic acid nor acetylsalicylic acid
induced quenching of the fluorescence shoulder.
From these data, we conclude that three character-
istic alterations to the fluorescence spectrum of
HucR are indicative of uric acid binding: (1)
quenching, observable at low concentrations of
ligand; (2) a red shift in the wavelength of
maximum fluorescence intensity; and (3) quenching
of the intensity of the shoulder at an emission
wavelength 10 nm below the wavelength of maxi-
mum intensity.
HucR mutants
The observation of negative cooperativity in uric
acid binding to HucR (Figure 4) is consistent with
three possible models: (1) there are at least two
separate uric acid-binding sites per HucR monomer
and the negative cooperativity exists between these
sites; (2) there is only one uric acid-binding site per
HucR monomer and the negative cooperativity is
between homologous sites in a homodimeric
assembly; or (3) there are multiple uric acid-binding
sites per monomer and the negative cooperativity is
between homologous sites in a homodimer. The co-
crystal structure of MarR with salicylate reveals
two binding pockets for salicylate within each
half of a homodimer, designated as sites SAL-A
and SAL-B.12 However, the physiological relevance
of these binding pockets remains to be determined,
as the protein crystals were saturated at the
exceedingly high concentration of salicylate of
250 mM.
Primary sequence alignment of HucR with its
most closely related homologs from the MarR
family revealed a high degree of conservation of
residues that form the ligand-binding pockets of
MarR.12,17 Most striking in the alignment is the
conservation of residues that form ligand-binding
pocket SAL-A in MarR. The guanidinium group of
R118 (numbering according to HucR primary
sequence) forms a hydrogen bond with the
carboxylate group of salicylate at this site (w3 Å);
R118 is strictly conserved in the alignment.17 The
threonine residue that hydrogen bonds to the
hydroxyl group of salicylate in site SAL-A (w3 Å)
is strictly conserved amongst the HucR homologs
in the alignment, but is replaced by a homologous
serine in HucR (S104). The hydrogen bonding
residues in site SAL-B are less well conserved in
the alignment, but HucR retains R109, which
coordinates with the carboxylate group of salicy-
late.
To determine whether the mechanism of ligand
recognition suggested by the MarR co-crystal
structure is retained by HucR, we generated two
HucR mutants, HucR-R118A and HucR-S104A,
each containing a single amino acid substitution in
ligand-binding site SAL-A. Secondary structure
prediction, sequence alignment against MarR, and
structural modeling of HucR (Figure 2) positions
R118 in the b-hairpin motif that forms the charac-
teristic “wing” structure of winged helix proteins
and positions S104 in the fifth a-helix of HucR that
forms the DNA recognition helix of the winged
helix motif. Therefore, changes in both the ligand-
binding and DNA-binding properties of HucR were
expected from each mutation.
DNA-binding properties of HucR mutants
We measured the affinities of HucR-R118A and
HucR-S104A for the HucR binding site, hucO.
EMSA revealed an apparent Kd of 0.1(G0.0) nM
(DGassocZK13.4 kcal/mol) for the interaction of
HucR-S104A with hucO, compared to the apparent
Kd of 0.3(G0.0) nM previously measured for wild-
type HucR (Figure 6). The affinity of HucR-R118A
for hucO was reduced approximately sixfold,
revealing an apparent Kd of 1.9(G0.1) nM (DGassocZ
K11.8 kcal/mol). The complex of each HucRmutant
with hucO dissociates during electrophoresis, as
reflected in a fractional saturation less than 100%
before correction for dissociation during electrophor-
esis. In addition, whereas only a single protein–DNA
complex is observed in each HucR and HucR-R118A
titration, a second complex may be distinguished at
high concentrations ofHucR-S104A. EMSAmeasure-
ments of DNA binding for the HucR variants under
stoichiometric conditions ([DNA][Kd) demon-
strated that HucR,17 HucR-S104A, and HucR-R118A
bind hucO at molar ratios of 1.9:1, 1.8:1, and 1.9:1,
respectively (data not shown), consistent with
fluorescence data (Figure 1(b)) and observations of a
pseudopalindromic binding sequence,17 indicating
Figure 5. HucR fluorescence spectra, normalized to the
fluorescence intensity maximum. Representative spectra
from one of two separate experiments, showing HucR in
the absence of uric acid (black, filled circle) or in the
presence of 30 mM uric acid (red, filled square), 200 mM
uric acid (blue, filled diamond), and 1 mM uric acid
(green, filled triangle).
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that HucR binds DNA as a dimer, suggesting that the
mutant proteins also approach 100% activity.
The protein–DNA complex instability observed
for both HucR-S104A and HucR-R118A suggested
the possibility that the DNA-binding specificities of
the HucR mutants were reduced, relative to the
wild-type. A measure of the sequence specificity in
binding by HucR-S104A and HucR-R118A was
obtained by a direct comparison of the abilities of
unlabeled hucO and pGEM5 to compete for protein
binding with 0.1 nM 32P-labeled hucO (Figure 7).
Reduced fractional saturation on the gel implies
competition in solution. Each HucR mutant is
highly sequence-specific in its DNA-binding
capacity, as reported for the wild-type protein.
Titration of unlabeled hucO to a concentration of
5 nM elicited a clear reduction in labeled complex
formation with HucR-S104A and HucR-R118A.
However, when using pGEM5 as a competitor,
only a slight reduction in the labeled hucO–protein
complex is observed at a concentration of 15 nM
pGEM5, for each mutant. Since pGEM5 contributes
a greater than 12-fold molar excess of base-pairs
compared to hucO, the competition assays demon-
strate the retention of a definite sequence-specific
binding for both HucR mutants.
Consistent with the apparent DNA binding
constants for the HucR variants (Figure 6), the
DNA-responsive intrinsic fluorescence spectra of
the proteins suggest altered mechanisms of DNA
association (Figure 8). A comparison of the intrinsic
fluorescence spectra of HucR, HucR-S104A, and
HucR-R118A reveals significant differences.
Whereas the measured fluorescence maximum is
at 338 nm for each protein, the peak intensity is 86.2
for HucR, 73.2 for HucR-S104A, and 111.6 for HucR-
R118A, suggesting that the environments of either
one, or both, of the tryptophan residues differ in
these HucR variants, and that each mutation causes
a global conformational change that propagates to
the globular interior and to the dimerization
domain; while a conformational change would be
needed to alter the environment of the trypto-
phan(s), such changes may be modest. When
complexed with a stoichiometric quantity of hucO,
such that all protein is expected to be in complex
with DNA, fluorescence quenching is observed for
each protein, indicating altered environments for
one or both tryptophan residues. However, the
degree of quenching induced by complex formation
differs significantly between the proteins. HucR
interaction with its cognate DNA-binding site leads
to a quenching of intrinsic fluorescence by 10.0%,
compared to 5.4% for HucR-S104A, and 22.2% for
HucR-R118A. From these two observations, we
conclude that protein conformational changes
upon DNA binding by HucR, HucR-S104A, and
HucR-R118A also differ.
Figure 6. Affinity measurements of HucR mutants for
the HucR binding sequence (hucO). (a)–(c) EMSAs in
which 0.1 nM hucO was titrated with protein. Uncom-
plexed hucO and protein–DNA complexes are identified
by arrows. (a) Wild-type HucR: 0, 0.05 nM, 0.125 nM,
0.25 nM, 0.5 nM, 1.0 nM, 2.5 nM, 5.0 nM, 15.0 nM.
(b) HucR-S104A; protein concentrations as for (a). (c)
HucR-R118A: 0, 0.25 nM, 0.5 nM, 2.5 nM, 5.0 nM,
10.0 nM, 15.0 nM, 20.0 nM. (d) Binding isotherms for
HucR-S104A (continuous line, filled circles; binding to
0.01 nM hucO) and HucR-R118A (broken line, filled
squares). Data were collected in triplicate. Fractional
saturation is reported as the meanGS.D.
Figure 7. Competition assays. Binding reactions
involved 0.1 nM 32P-labeled hucO and titration of up to
15 nM unlabeled hucO or pGEM5, followed by the
addition of protein. Complexes were resolved by
EMSAs. The first lane in each gel contains only labeled
DNA. Concentrations of unlabeled competitor DNA are
indicated above the corresponding lanes. Complexed and
uncomplexed hucO are identified by arrows. (a) HucR-
S104A, (b) HucR-R118A.
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Uric acid binding by HucR mutants
As both R118 and S104 mediate hydrogen bond
contacts with a ligand in the crystal structure of
MarR, and as both of these residues are highly
conserved in theMarR family, we analyzed the roles
of each of these side-chains in uric acid recognition
by HucR. For each HucR mutant, increasing
concentrations of uric acid reduced formation of
the protein–hucO complex (Figure 9(a) and (b)).
However, in contrast to the case of wild-type HucR,
where DNA complex formation was abolished in
the presence of approximately 1 mM uric acid, we
observed faint smears extending above the band of
free hucO at concentrations of uric acid up to
10 mM. This effect was shown not to be a result of
uric acid or its solvent affecting the DNA migration
(data not shown). Additional controls confirmed
that the uric acid solvent did not affect formation of
the protein–hucO complex (data not shown). We
therefore interpreted the smearing above the band
of free DNA to be residual DNA complex formation
with HucR-S104A and HucR-R118A. At concen-
trations of uric acid below 1 mM, a steep decrease in
normalized DNA complex formation is seen for all
three variants (Figure 9(c)). At concentrations of
uric acid above 1 mM, the antagonistic effect of uric
acid approaches saturation; for wild-type HucR,
fractional complex saturation approaches zero
while fractional saturation for the HucR-mutants
near saturation at w30%. At 10 mM uric acid,
approximately 20% of the HucR-S104A complex
remains and approximately 10% of the HucR-
R118A complex remains.
In addition to affects on DNA affinity, the S104A
and R118A amino acid substitutions in HucR,
therefore, each appear to reduce the response of
the protein to high concentrations of uric acid. The
data are consistent with there being at least two
separate uric acid-binding sites in HucR with
dissimilar ligand affinities. Our data suggest that
the mutations at HucR positions 104 and 118,
corresponding to ligand-binding pocket SAL-A in
MarR, each affect a lower-affinity uric acid-binding
site.
The interaction of uric acid with HucR-S104A
and HucR-R118A was measured by intrinsic
fluorescence (Figure 10(a)). For HucR-S104A, the
Figure 8. Fluorescence spectra of free and DNA-bound
HucR variants. The intrinsic fluorescence spectrum is
shown for 1.52 mM each HucR variant before (continuous
line, filled circles) or after (broken line, open triangles)
incubation with 0.76 mM hucO-31. (a) Wild-type HucR,
(b) HucR-S104A, and (c) HucR-R118A.
Figure 9. DNA-binding antagonism by uric acid.
Protein–hucO association was challenged with increasing
concentrations of uric acid, and complexes resolved by
EMSA. Reactions contained 0.1 nM 32P-labeled hucO.
Lane 1 contains free DNA. For protein-containing
reactions, uric acid concentrations are 0, 0.1 mM,
0.5 mM, 1, 5 mM, and 10 mM. (a) HucR-S104A. (b)
HucR-R118A. (c) Normalized protein–hucO complex
formation as a function of uric acid concentration for
wild-type HucR (continuous line, filled circles), HucR-
R118A (broken line, filled squares), and HucR-S104A
(dotted line, filled triangles). Experiments were per-
formed in triplicate and data are reported as meanGS.E.
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apparent Kd for interaction with uric acid was 7.4(G
0.5) mM, compared to 9.7(G3.3) mM for HucR-
R118A, and 11.6(G3.7) mM for HucR. Interestingly,
the negative cooperativity in uric acid binding by
HucR was reduced, or lost, through the S104A and
R118A mutations. Whereas HucR displayed an nH
of 0.7G0.1, fits for HucR-S104A and HucR-R118A
revealed nH values of 1.1G0.1 and 0.9G0.2,
respectively. Scatchard representations of uric
acid-induced quenching of mutant fluorescence
were linear. As for the wild-type protein, fits of
the data for the mutants to an equation for non-
equivalent, independent sites resulted in large
error. As measurements of fluorescence quenching
at low concentrations of uric acid predominantly
monitors binding at a high-affinity site(s), the
unchanged, or small increase in, affinity for uric
acid observed for both HucR mutants is consistent
with each mutation residing in a low-affinity uric
acid-binding site.
We then compared the effects of uric acid on the
normalized fluorescence spectra of HucR, HucR-
S104A, and HucR-R118A. The uric acid-induced red
shift in the wavelength of maximal fluorescence
intensity for HucR was observed in both HucR
mutants (Figure 10(b) and (c)). For each protein, the
wavelength of maximal intensity shifted from
338 nm, for the apo protein, to 341 nm at 200 mM
uric acid and remained at 341 nm at a ligand
concentration of 1 mM. The reduction of the
shoulder fluorescence intensity relative to the
peak intensity observed in HucR was retained in
both HucR mutants, even at low concentrations of
uric acid. We therefore concluded that these effects
on the fluorescence spectra were induced by ligand
binding at a site that was unaltered by the separate
mutations at S104 and R118. Moreover, as the red-
shift and shoulder-quenching effects were observed
at concentrations of ligand below 50 mM, we
conclude that these effects correspond to binding
at a high-affinity site(s) and that the S104A and





The conformational changes observed in HucR
and the DNA upon binding indicate that the
interaction is not static. Rather, a DNA distortion
is observed that may indicate a decrease in the
duplex winding angle (Figure 1(a)). This is consist-
ent with the mechanisms of site-specific DNA
binding by winged helix proteins from the MerR
family, which have been shown to decrease the
helical twist of the DNA duplex, and bend the
double helix, upon formation of complex.30,31 As
the center of each inverted repeat in the HucR
binding site is separated by one full turn of double
helix, it is tempting to speculate that unwinding of
the double helix is required to accommodate
insertion of the recognition helices of an HucR
homodimer into consecutive, major grooves. In the
absence of a crystal structure of a DNA-bound
MarR homolog, this is the first piece of evidence
suggesting that alteration of the helical twist of the
DNA duplex is required to accommodate binding
by these proteins.
Quenching of the intrinsic fluorescence of HucR
upon DNA complex formation suggests confor-
mational changes in the homodimer that extend
beyond the helix-turn-helix and wing motifs that
are predicted to make all direct contacts with DNA;
the two HucR tryptophan residues are expected to
be in the globular interior of the protein and at the
dimer interface (Figures 1(b) and 2). Quenching of
Figure 10. Fluorescence detection of uric acid binding
to HucR mutants. (a) Binding isotherms for protein–uric
acid interactions. Quenching of protein fluorescence at
338 nm is plotted against concentration of uric acid for
wild-type HucR (continuous line, filled circles), HucR-
R118A (broken line, filled squares), and HucR-S104A
(dotted line, filled triangles). (b) and (c) Fluorescence
spectra, normalized to the fluorescence intensity maxi-
mum, for protein in the absence (black, filled circles) or
presence of 30 mM (red, filled squares), 200 mM (blue,
filled diamond), and 1 mM (green, filled triangles) uric
acid. (b) HucR-S104A. (c) HucR-R118A.
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the intrinsic fluorescence of the indole ring of
tryptophan has been associated with conformation-
al shifts to three altered environments: (1) increased
solvent exposure; (2) closer contact with amide
bonds in the peptide backbone; or (3) closer contact
with polar side-chains.32,33 Additional work will be
required to elucidate the nature of the confor-
mational changes induced in HucR and its cognate
DNA-binding site upon formation of the complex.
HucR DNA-binding mechanism
Given the predicted locations of S104 and R118 in
the DNA recognition helix and wing of HucR,
respectively, it is not surprising that substitutions at
these positions affect HucR–hucO association
(Figure 6). The protein–DNA complex stability for
each HucR-mutant, relative to that of wild-type
protein, is reduced on the gel; we cannot say if this
relative instability is present in solution. However,
an increased koff would explain the increased Kd
observed for HucR-R118A. Also consistent with the
altered apparent Kd values for each mutant are the
intrinsic fluorescence data, suggesting altered
DNA-binding mechanisms (Figure 8).
The effects of the individual mutations on DNA
binding support the prediction that HucR mediates
binding via a winged helix fold. In addition, the
decreased affinity for the HucR binding site, elicited
by the R118A mutation, suggests strongly that the
b-hairpin wing, and not just the recognition helix,
makes direct contacts with the DNA duplex.
Moreover, the high degree of amino acid conserva-
tion in the wing region of MarR homologs suggests
its importance in directing association with DNA.17
HucR–uric acid association and negative
cooperativity
The apparent Kdw12 mM for binding of uric acid
to HucR indicates an affinity significantly higher
than has been observed for MarR, whose affinity for
the phenolic compounds salicylate, plumbagin,
2,4-dinitrophenol, and menadione was 500 mM,
250 mM, 250 mM, and 800 mM, respectively,8,11,34
but similar to the drug-binding affinities of the
MarR homolog, EmrR, which binds phenolic
ligands with a Kd of 2.0–15.0 mM.
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Our data suggest that the HucR monomer
contains at least two separate uric acid-binding
sites with dissimilar affinities, and that the HucR
site corresponding to the MarR ligand-binding
pocket SAL-A binds uric acid with low affinity.
The significant conservation of residues comprising
SAL-A suggests that SAL-A is a low-affinity site in
MarR, as well. These conclusions are based upon
the following observations. (1) Uric acid-induced
quenching of HucR intrinsic fluorescence reveals
negative cooperativity, indicating that at least two
uric acid-binding sites are involved (Figure 4). Uric
acid quenching predominantly monitors binding at
a high-affinity site(s) as indicated by the poor fit of
the data to equations for multiple, non-equivalent,
non-interacting sites, suggesting that negative
cooperativity is between homologous sites in each
monomer. (2) The S104A and R118Amutations each
result in little to no change in uric acid-binding
affinity, suggesting that each residue resides in a
low-affinity, ligand-binding site (Figure 10). Each
mutation removes the cooperativity of uric acid
binding, consistent with each mutation residing in
the same binding site. (3) The alterations to the
normalized fluorescence spectra observed at con-
centrations of uric acid up to 1 mM were nearly
identical for all three HucR variants, indicating that
these effects were induced by ligand binding at a
site unaltered by the separate S104A and R118A
mutations (Figures 5 and 10(b) and (c)). Moreover,
as these alterations to the emission spectra occurred
at concentrations of uric acid below 50 mM, we
conclude that these effects correspond to binding at
high-affinity site(s). (4) Increasing concentrations of
uric acid up to 1 mM result in a similar, steep
antagonism of HucR–hucO complex formation for
HucR, HucR-S104A, and HucR-R118A (Figure 9).
However, unlike HucR, residual protein–DNA
complex is observed for both HucR mutants up to
10 mM uric acid. These observations are consistent
with each mutation residing in a low-affinity,
ligand-binding site.
The loss of uric acid binding cooperativity
induced by each mutation, combined with the
differences in the intrinsic fluorescence spectra of
the HucR variants (Figure 8), suggests the possi-
bility that each mutation propagated a confor-
mational change in HucR that disrupted the
cooperativity between the high-affinity site(s) in
each half of the homodimer. Alternatively, uric acid
binding at the low-affinity site (containing HucR
residues S104 and R118) might stabilize the
recognition helix in a position such that ligand
binding at the high-affinity site might reduce the
affinity of the corresponding site in the adjacent
monomer. This latter model is consistent with the
expected juxtaposition of the SAL-B ligand-binding
sites in the cleft between the HucR subunits of the
homodimer. The data do not rule out the possibility
that the negative cooperativity in HucR is between
the low-affinity site comprised of residues S104 and
R118, and a separate high-affinity site(s). However,
ligand binding in the low-affinity, SAL-A site is
unlikely to be involved in negative cooperativity,
based on our observation that negative cooperativ-
ity is seen at concentrations of uric acid below
50 mM, where site SAL-A is probably not filled.
It has been proposed that the physiological
benefit of negative cooperativity is that it increases
the range of concentration over which the protein
can respond.32,35 In addition, negative cooperativity
can increase the protein’s sensitivity to low
concentrations of ligand. Given the tendency of
uric acid to precipitate and the consequential
deleterious effects to the cell, it would likely be
advantageous for D. radiodurans to upregulate uri-
case in response to low concentrations of uric acid.
However, given the ability of uric acid to scavenge
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damaging reactive oxygen species,36,37 it seems
beneficial to the cell for the uric acid-modulated
response of uricase expression to be attenuated,
such that an optimal concentration of uric acid is
maintained below a critical threshold where pre-
cipitation would occur. Negative cooperativity
could extend the range of uric acid concentration
over which HucR can respond, by effectively
increasing the concentration of uric acid at which
all HucR-mediated uricase repression is relieved,
thus allowing a basal level of uric acid to remain in
the cell. Simultaneously, negative cooperativity
would effectively decrease hucR transcription at
low concentrations of uric acid, likely to maintain
an optimal level of uricase in the cell.
In a similar light, uric acid-binding site SAL-A in
HucR may be physiologically relevant. As
suggested by Figure 9, uric acid binding in site
SAL-A (in addition to binding at high-affinity
site(s)) would reduce DNA-binding affinity relative
to that of HucR with only the high-affinity site(s)
filled. Such a system may serve to provide a
constitutive level of uricase repression at concen-
trations of uric acid below a dangerous threshold;
only if the cellular concentration of uric acid
becomes high enough, would site SAL-A be filled,
resulting in maximal uricase expression.
Possible basis for changes in the fluorescence
spectrum of HucR on ligand or DNA binding
W20 of HucR is predicted to reside in an
a-terminal a-helix that, on the basis of the MarR
and MexR crystal structures, likely forms the
hydrophobic dimer interface.12,18 On the basis of
the MarR-salicylate co-crystal structure, movement
of the DNA-binding domains to accommodate
DNA binding would require significant distortion
of MarR a-helix 1 and the C-terminal a-helices.8,12
The multiple structural views of the MexR homo-
dimer indicate significant flexibility in the dimeri-
zation domain, as observed in a 178 deviation in the
helix orientation of a-helix 1, and a 4.9 Å shift in its
helix midpoint position.18 Moreover, as dimeri-
zation of both MexR and MarR is mediated
primarily by van der Waals contacts involving
their respective N and C-terminal helices, flexibility
in this domain is expected, as such hydrophobic
interactions do not require specific molecular
orientations. Except for the wing itself, the MexR
winged helix DNA-binding domain appears to be
considerably less flexible; rather, each domain
moves as a rigid body relative to the homologous
domain in the dimer.18 HucR a-helix 3, which
contains W72, corresponds to the first helix in this
motif. Though we do not know the magnitude of
the conformational changes that alter the environ-
ments of the HucR fluorophores, the alterations of
the HucR fluorescence spectrum observed upon
DNA binding and ligand binding are consistent
with conformational changes in the dimerization
domain containing HucR tryptophan 20 and/or
rigid movements of HucR helix 3 in the winged-
helix DNA binding domain.
Proposed mechanism for uric acid-mediated
allosteric control of HucR–DNA complex
formation
Though there is considerable variability in the
mechanisms of allosteric control of the DNA-
binding properties of homodimeric winged helix
proteins, the effector binding domains are generally
distal to the winged helix domains, and ligand-
induced conformational changes are propagated to
the winged helix motif.38 Indeed, all characterized
prokaryotic multidrug-binding transcriptional reg-
ulators other than MarR incorporate a spatial
separation of ligand-binding and DNA-binding
domains.34,39 Even though the MarR family is
proposed to share a common evolutionary history
with the GntR, MerR, and Crp families,40 MarR
proteins appear to have an interesting structural
organization, such that the ligand-binding and
winged helix DNA-binding domains overlap
almost completely.
The MexR structure reveals an “open” dimer
conformation in which basic charge repulsions
between the two DNA-binding domains maintain
the dimer in a conformation that can be docked onto
the known MexR DNA-binding site.18 Comparison
to another MexR dimer suggested a mechanism of
allosteric control in which the binding of a potential
effector between the two DNA-binding domains
neutralizes protein charges and mediates hydro-
phobic bonds with protein side-chains, resulting in
a reduction in the relative distance between the
DNA-binding domains to become incompatible
with DNA binding.
HucR is strongly electropositive in its proposed
DNA-binding region, and uric acid could serve to
neutralize charge repulsions that maintain the
DNA-binding lobes of the HucR dimer in a DNA-
binding conformation. The hydrophobic rings of
uric acid could potentiate van der Waals inter-
actions with hydrophobic HucR side-chains, further
distorting the relative conformations of the sub-
units. It is likely that the uric acid-binding site
mediating such conformational events corresponds
to ligand-binding site SAL-B in MarR. Ligand-
binding site SAL-A is located between the DNA
recognition helix and the wing region, whereas site
SAL-B is located on the other side of the DNA
recognition helix; the two SAL-B sites in the
homodimer would be positioned in the channel
between the DNA-binding lobes (6 Å wide in the
MarR structure). Binding of uric acid at such a
position could potentially disrupt the relative
orientation of the HucR DNA-binding domains.
Such a perturbation of the spatial separation of the
recognition helices in the homodimer would be
dependent upon the flexibility of the dimerization
domain suggested by the fluorescence data. Sup-
port for our observation that site SAL-A in HucR
is a low-affinity, ligand-binding site and our
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hypothesis that site SAL-B mediates allosteric
events comes from the fact that the residues that
comprise ligand-binding site SAL-A, but not SAL-B,
are highly conserved in MexR, and MexR does not
respond to salicylic acid as an effector.18 This
suggests that SAL-A is a low-affinity site in MarR.
The significant changes in the fluorescence
spectrum of HucR that are induced upon binding
uric acid and DNA likely correspond to alterations
in the environments of both tryptophan residues
(though we do not know to what extent each
contributes). According to this hypothesis, uric acid
would distort the relative positions of the DNA-
binding domains in the homodimer, thus altering
the environment of tryptophan 72. Suchmovements
of the winged-helix domains would require flexi-
bility of the N-terminal a-helices of each monomer,
altering the environment of HucR tryptophan 20.
Similarly linked movements would be expected for
the HucR dimer to adopt a DNA-binding confor-
mation.
Materials and Methods
Circular dichroism (CD) spectroscopy
Complementary synthetic oligonucleotides were gel-
purified and annealed to generate a 31 bp fragment
(hucO-31) containing the HucR-binding site, spanning the
sequence K23 to C8 relative to the putative transcrip-
tional start site of dr1160. CD spectroscopywas performed
on an AVIV 202 CD spectrophotometer using a quartz
cuvette with a 1 cm pathlength. DNA was diluted to a
final concentration of 2 mM in CD buffer (20 mM
potassium phosphate (pH 7.0), 50 mM KCl) and titrated
with concentrated HucR to a final concentration of 4 mM
monomer. After each titration, samples were equilibrated
at 25 8C for 15 minutes before data were collected.
Ellipticity measurements were collected at 25 8C from
340 nm to 190 nm in steps of 1 nm. All data were
corrected for buffer contributions to the signal, and
samples containing HucR were corrected for additional
ellipticity contributions from the protein. Experiments
were performed in duplicate (with representative data
reported from one experiment).
Intrinsic fluorescence measurements
Fluorescence emission spectra from 280 nm to 440 nm
were recorded on a Jasco FP-6300 spectrofluorimeter with
an excitation wavelength of 280 nm at 25 8C using a
0.5 cm pathlength cuvette. All experiments were per-
formed with 0.03 mg/ml of protein (1.52 mMwild-type or
mutant HucR) in 40 mM Tris–HCl (pH 8.0), 0.2 mM
EDTA, 0.1% (w/v) BRIJ 58, 100 mM NaCl, and 10 mM
MgCl2, unless stated otherwise. Parallel absorbance
spectra were recorded for each sample from 190–
450 nm. For measurements of protein–hucO-31
complexes, HucR (wild-type or mutant) was titrated
with concentrated hucO-31, mixed, and equilibrated for
15 minutes before scanning. For the protein–ligand
binding assays, stock solutions of uric acid, salicylic
acid, and acetylsalicylic acid were prepared as
described.17 Serial ligand dilutions were prepared such
that the addition of 0.5 ml to the protein sample would
attain the desired concentration of ligand. Samples were
mixed and incubated for 60 seconds before each scan.
The corrected protein fluorescence intensity at each
wavelength (Fcorr(l)) was obtained from the observed
fluorescence by first correcting for dilution from titration
and background fluorescence to obtain Fc(l). Inner filter




where Aex and Aem are the absorbance at the excitation
and emission wavelengths, respectively.41 Fcorr(l) is only
reported for samples where both Aex and Aem are less
than 0.2. For ligand-binding assays where Aex exceeded
0.2, normalized fluorescence intensities were obtained by
partial correction of the inner filter effect (Fpcorr(l)):
FpcorrðlÞZFcðlÞ!10
ðAem=2Þ
before being normalized to the maximal Fpcorr. For
fluorescence measurements involving acetylsalicylic
acid, Fc(l) was calculated by incorporating an additional,
experimentally determined factor to correct for quench-
ing resulting from the solvent, ethanol.
Percentage quenching (%Q) induced by DNA binding
was calculated by:
%QZ 100ð1K ðFcorrð338 nmÞfProtein
CDNAg=Fcorrð338 nmÞfProteingÞÞ
For ligand binding at low concentrations of ligand,
quenching at 338 nm (Q338)was calculated by:
Q338 Z 1K ðFcorr½X=Fcorr½0Þ
where Fcorr[X] and Fcorr[0] are the corrected fluorescence
intensities at 338 nm for ligand concentrations X mM and
0 mM, respectively. As a control, no uric acid-induced
quenching of lysozyme fluorescence was observed up to
50 mM uric acid. Uric acid-binding isotherms were
generated by non-linear fits to the Hill equation:
Q338 Z fnð1=KdÞ
nH ðUÞnH g=ð1C ð1=KdÞ
nH ðUÞnH Þ
where n represents the quenching plateau, U is the
concentration of uric acid, Kd is the observed dissociation
constant, and nH is the Hill coefficient. Data are reported
as the meanGS.D. for two separate experiments.
Sedimentation equilibrium
A 150 ml HucR sample at A280Z0.65 was dialyzed
overnight at 4 8C against 350 ml of AU buffer (20 mM
Tris–HCl (pH 8.0), 50 mM NaCl, 5 mM MgCl2). The
reference and solution sectors of an analytical cell with a
double-sector centerpiece were loaded with 125 ml of AU
buffer and 110 ml of HucR sample, respectively. Equili-
brium analysis was performed at 20 8C at 10,000 rpm
using a Beckman Optima XL-A analytical ultracentrifuge
equipped with a An-60 Ti rotor. The cell was scanned at
294 nm at five hour intervals with a step size of 0.004 cm
until the system reached equilibrium. The partial specific
volume of HucR at 20 8C was determined to be
0.7387 cm3/g from the primary amino acid sequence
using the program SEDNTERP, and the solution density
calculated to be 1.00120 g/cm3. Equilibrium sedimen-
tation data were analyzed using Origin Equilibrium
software and fit to an equation describing a single ideal
protein species. Fits of the data to models describing a
self-associating system resulted in molecular mass
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calculations with large error and that were not multiples
of the HucR molecular mass.
Cloning, overexpression, and purification of HucR
mutants
Primers were designed to introduce the desired amino
acid substitutions into the hucR coding sequence via
whole plasmid PCR using the recombinant plasmid
pSPW1, which contains the hucR coding region as a
template.17 Arginine 118 was converted to alanine using
primers R118A-FWD (5 0-CTG ATC GAGGCC CGC GAG
GAC-3 0; nucleotide substitutions yielding R118/A in
bold) and R118A-REV (5 0-GCC CTT TTC GAG CAG CCG
CAC- 3 0). Serine 104 was converted to alanine using
primers S104A-FWD (5 0-CCT TCG ACG GCC AAC CGG
ATC-3 0; nucleotide substitutions yielding S104/A in
bold) and S104A-REV (5 0-CCC GGA AAT GGC GGC
CAG G-3 0). PCR products were treated with DpnI and
transformed into E. coli TOP10 (Invitrogen). The fidelity
of the recovered plasmids, identified as pR118A and
pS104A, was verified by DNA sequencing. Plasmids
pR118A and pS104A were transformed individually into
E. coli BL21(DE3)pLysS. HucR mutants were expressed,
and cells lysed essentially as described for wild-type
HucR, with the exception that protein expression was
induced with 0.8 mM isopropyl-1-thio-b-D-galactopyra-
noside for 75 minutes.17 Cell lysates were precipitated on
ice with ammonium sulfate to 60% saturation and the
resulting pellets resuspended in 100 ml of the appropriate
buffer: for HucR-R118A purification, HA buffer (20 mM
Tris–HCl (pH 7.5), 50 mMKCl, 4.8% (v/v) glycerol, 1 mM
Na2EDTA, 4.3 mM 2-mercaptoethanol, 0.2 mM phenyl-
methylsulfonyl fluoride) and for HucR-S104A purifi-
cation, HAPT buffer (20 mM potassium phosphate (pH
6.0), 50 mM KCl, 10% (v/v) glycerol, 1 mM Na2EDTA,
0.02% (v/v) Tween-20, 4.3 mM 2-mercaptoethanol,
0.2 mM phenylmethylsulfonyl fluoride) and sub-
sequently dialyzed overnight against 40 volumes of the
respective buffer (this and all subsequent purification
steps were performed at 4 8C). Each dialysate was
subsequently centrifuged at 11,000 g for 20 minutes and
the supernatants processed as described below.
For HucR-R118A purification, the supernatant was
loaded onto CM-cellulose and DEAE-Sepharose columns
linked in tandem and equilibrated with HA buffer (pH
7.5). The HucR-R118A-containing flow-through and wash
fractions were dialyzed against HAP buffer (pH 6.0)
(same as HA buffer, except that 20 mM potassium
phosphate (pH 6.0) replaces Tris–HCl) and loaded onto
a CM-cellulose column equilibrated with HAP buffer (pH
6.0). The HucR-R118A-containing flow-through was
loaded onto a hydroxyapatite column equilibrated with
HAP buffer (pH 6.0). The HucR-R118A-containing flow-
through and wash fractions were loaded onto a heparin
column equilibrated with HAP buffer (pH 6.0). HucR-
R118A was eluted with a linear gradient of 50 mM–1 M
KCl in HAP buffer (pH 6.0). Peak fractions were pooled,
dialyzed against HAP buffer (pH 6.0), and loaded onto a
Cibacron Blue 3GA column equilibrated with HAP buffer
(pH 6.0). The column was eluted with a linear gradient of
50 mM–1 M KCl and peak fractions pooled. HucR-R118A
was concentrated, and the concentration of KCl reduced
to w50 mM, using a Centriprep centrifugal filter device.
The concentration of glycerol was subsequently increased
to 20%.
For HucR-S104A purification, the supernatant was
loaded onto a CM-cellulose column equilibrated with
HAPT buffer (pH 6.0). The HucR-S104A-containing
flow-through and wash fractions were loaded onto a
heparin column equilibrated with HAPT buffer (pH 6.0).
The HucR-S104A-containing wash was loaded onto a
Cibacron Blue 3GA column equilibrated with HAPT
buffer (pH 6.0). The column was eluted with a linear
gradient of 50 mM–1 M KCl and peak fractions pooled.
HucR-S104A was concentrated and the concentration of
KCl reduced to w50 mM. The concentration of glycerol
was subsequently increased to 20%.
Each mutant was purified to greater than 95%
homogeneity, as determined by SDS-PAGE (Supplemen-
tary Data, Figure S2). HucR-R118A and HucR-S104A
concentrations were determined spectrophotometrically
using 3280Z13,512 M
K1 cmK1 and verified by SDS-PAGE
using bovine serum albumin (BSA) as a standard.
Electrophoretic mobility-shift assay (EMSA)
The DNAused for protein–DNA affinity measurements
was prepared by PCR amplification from theD. radiodurans
genome, as described, and spans a 180 bp sequence
containing a single HucR binding site.17 The resulting
PCR product, hucO, was gel-purified and 32P-labeled with
phage T4 polynucleotide kinase. EMSAwas performed as
described for the wild-type protein.17 For HucR-R118A
and HucR-S104A DNA-affinity determination, 0.1 nM or
0.01 nM 32P-labeled hucO, respectively, was titrated with
up to 20 nM or 15 nM protein dimer. The exponential
decay constant for each complex dissociation in the gel
was calculated and fractional saturation corrected, as
described.42 Each binding isotherm was generated by a
non-linear fit of three data sets to the equation:
Fractional saturation of hucOZ ðnðPÞ=KdÞ=ð1C ðP=KdÞÞ
where n represents maximal fractional saturation, P is the
concentration of free protein dimer, and Kd is the apparent
equilibrium dissociation constant. Each Kd is reported as
the meanGS.D. Calculated values of n from the HucR-
S104A and HucR-R118A binding isotherms were 0.9G0.0
and 1.0G0.0, respectively. Measured complex was
identical for binding incubation times of 45 seconds to
60 minutes, indicating that thermodynamic equilibrium is
reached quickly (data not shown). The DNA-binding
stoichiometry of HucR mutants was determined by
titrating 0.1 mM labeled hucO with up to 0.5 mM protein
monomer. Binding conditions for the competition assays
were as described above, except that a slightly larger, gel-
purified PCR product of 241 bp was used (containing a
single HucR binding site). Each binding reaction con-
tained 0.1 nM 32P-labeled hucO titrated with up to 15 nM
unlabeled hucO or pGEM5. Protein was added last to the
binding reactions, at a final concentration of 2.5 nM
HucR-S104A dimer or 10 nM HucR-R118A dimer. Pro-
tein–hucO binding conditions for HucR-S104A andHucR-
R118A, analyzing uric acid as an effector, were as
described for wild-type HucR, except that protein dimer
concentrations were 3.75 nM and 12.5 nM for HucR-
S104A and HucR-R118A, respectively. Data were fit to an
equation for two single-exponential decays:




where L is the concentration of uric acid, n1 and n2 are
fractional complex amplitudes, and j and k are decay
constants. Fits to a single exponential resulted in lower R2
values relative to fits to a double exponential (e.g. for
HucR-S104A, R2Z0.8390 and 0.9984, respectively).
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6. Cohen, S. P., Hächler, H. & Levy, S. B. (1993). Genetic
and functional analysis of the multiple antibiotic
resistance (mar) locus in Escherichia coli. J. Bacteriol.
175, 1484–1492.
7. Sulavik, M. C., Gambino, L. F. & Miller, P. F. (1994).
Analysis of the genetic requirements for inducible
multiple-antibiotic resistance associated with the
mar locus in Escherichia coli. J. Bacteriol. 176,
7754–7756.
8. Martin, R. G. & Rosner, J. L. (1995). Binding of purified
multiple antibiotic-resistance repressor protein
(MarR) to mar operator sequences. Proc. Natl Acad.
Sci. USA, 92, 5456–5460.
9. Cohen, S. P., Levy, S. B., Foulds, J. & Rosner, J. L.
(1993). Salicylate induction of antibiotic resistance
in Escherichia coli: activation of the mar operon and
a mar-independent pathway. J. Bacteriol. 175, 7856–
7862.
10. Seoane, A. S. & Levy, S. B. (1995). Characterization of
MarR, the repressor of the multiple antibiotic
resistance (mar) operon in Escherichia coli. J. Bacteriol.
177, 3414–3419.
11. Alekshun, M. N. & Levy, S. B. (1999). Alteration of the
repressor activity of MarR, the negative regulator of
the Escherichia coli marRAB locus, by multiple
chemicals in vitro. J. Bacteriol. 181, 4669–4672.
12. Alekshun, M. N., Levy, S. B., Mealy, T. R., Seaton, B. A.
& Head, J. F. (2001). The crystal structure of MarR, a
regulator of multiple antibiotic resistance, at 2.3 Å
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